News | May 08, 2007

University-Based Illumasonix Blends Best of Ultrasound, MR to Detect Vascular Blockage

May 9, 2007 — Allied Minds, an investment corporation specializing in early stage university business ventures, has teamed with the University of Colorado to establish Illumasonix LLC, a start-up company that is developing a noninvasive method to provide quantitative information on complex blood flow in the treatment of vascular disease.

Current diagnosis of cardiovascular and neurovascular diseases utilizes ultrasound and MRI technology, which is limited in its capacity to determine whether disease is progressing or stabilized. Ultrasound provides good temporal resolution but only provides one-dimensional velocity measurement and angular error. MRI phase velocity mapping offers multicomponent velocity data and high spatial resolution, but poor temporal resolution. The goal of Illumasonix is to combine the advantages of MRI with the temporal resolution and ease-of-use of ultrasound.

Dr. Robin Shandas, professor of Mechanical Engineering at the University of Colorado at Boulder and of Pediatrics and Cardiology at the University of Colorado, Denver and Health Sciences Center, is developing a system that uses ultrasound and FDA-approved microbubbles to track blood flow. This process will easily provide real-time assessment of blood flow and detect blockages.

"Our technology is intended to create a new high resolution ultrasound procedure to better detect vascular disease," said Dr. Shandas.
For more information visit www.illumasonix.com.

Related Content

High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Contrast-Free Cardiac MRI May Better Assess Need for Mitral Valve Surgery
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
A new study published in the Journal of the American College of Cardiology confirms non-invasive cardiac magnetic...
The FDA has cleared the Toshiba Vantage Galan 3.0T XGO Edition MRI from Canon Medical Systems.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac ...
Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI) | January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI) | December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Overlay Init